Status:
UNKNOWN
Efficacy of Myofascial Release in Patients With Axial Spondyloarthritis.
Lead Sponsor:
Universidad de la Sabana
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Axial spondyloarthritis (AS), is a chronic and disabling disease that mainly affects young people, generating clear limitations in mobility and functional capacity in patients who develop this disease...
Detailed Description
Trial design: Controlled parallel double blind superiority clinical trial. Participants of the trial: Patients with a diagnosis of axial spondyloarthritis, of legal age, attending the rheumatology ser...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of ankylosing spondyloarthritis confirmed by rheumatologist regardless of the level of disease activity.
- Patients with cognitive ability to follow orders.
- Patients who agree to participate in the study and firm informed consent.
Exclusion
- Patients receiving oral or parenteral coagulation therapy.
- Pregnant women
- Patients with Kinesiophobia.
- Patients with previous physical therapy in the last 15 days.
- Presence of active cancer, current treatment in chemo or radiotherapy.
- Patients who do not wish to participate in the study
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT04424589
Start Date
December 1 2020
End Date
June 1 2021
Last Update
June 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.